
A Critique Of The FAO-CGIAR Trusteeship System
Genetic Resources Action International (GRAIN)
This critique discloses weaknesses in the genebank system managed by the
Consultative Group in International Agricultural Research (CGIAR). It
contends that the problems originated from a little known agreement between
CGIAR and the U.N. Food and Agriculture Organization (FAO) to create a
"trusteeship" system. According to the article, the agreement's intention
was to establish legal and political protection from the misappropriation
of germplasm held in the genebanks. The CGIAR has been responsible for
collecting, maintaining, and distributing farmer-bred plant varieties for
use in the "public domain." The article suggests that CGIAR's secondary
motive is to make farmer-bred plant varieties "effortlessly declared public
property so that [CGIAR] scientists can freely continue their work." The
article also asserts that the trusteeship system has failed to prevent some
donated plant varieties from being claimed as intellectual property. While
CGIAR-distributed genetic material cannot be patented "in the form
received," the article says that a recipient of two similar plant varieties
could "cross them together and patent the offspring." In addition, the
article castigates the CGIAR for allowing the commercialization of its
germplasms and emphasizes that the derived financial benefits have not been
shared with the farmers who originally donated seeds to the genebanks. The
article predicts that FAO and CGIAR negotiators will experience
difficulties in agreeing on provisions that would reformat the trusteeship
system to comply with the International Treaty on Plant Genetic Resources
for Food and Agriculture. The piece recommends an alternative: that CGIAR
and FAO should "start from scratch and redesign the whole system rather
than simply update it." The article can be viewed online at the link below.
** NOTICE: In accordance with Title 17 U.S.C. Section 107, this material is distributed for research and educational purposes only. ** |
|
|
Last Updated on 10/3/02 Email: information@biotech-info.net |
|